![FDA, FTC and DOJ Enforcement of Medical Device Regulations FDA, FTC and DOJ Enforcement of Medical Device Regulations](https://www.fdanews.com/ext/resources/Book-Covers-2/BFFDEMDR-COVER.png?height=200&t=1685733565&width=200)
Home » Co-Diagnostics Gains CE Mark for ZDC Multiplex Test
Co-Diagnostics Gains CE Mark for ZDC Multiplex Test
![](https://www.fdanews.com/ext/resources/test/Device_Images6/Co-Diagnostics_Logo.gif?t=1552016694&width=430)
Co-Diagnostics received the CE Mark for its Logix Smart Zika/Dengue/Chikungunya in vitro diagnostic test and the company is now producing the multiplex test at its facility in Salt Lake City, Utah.
The Logix Smart test detects the three mosquito-transmitted viruses in patients and distinguishes between them by analyzing their RNA. If a specimen tests positive for Zika, a cerebral spinal fluid sample can be taken to look for neurological infection.
Zika, dengue and chikungunya all have similar symptoms — such as joint pain and severe fever — and can be misdiagnosed by physicians.
Upcoming Events
-
21Oct